Stockgram
Q4 Results Live Updates: Honasa Consumer revenue up 13%; ITC shares slips 2% ahead of earnings Gulf Oil eyes higher margin in FY26, bets on premium lubricants and EV growth Clarity on expiry dates to come this month: SEBI chief Tuhin Kanta Pandey India-US yield gap hits over two-decade low—Will It narrow further? US Stock Market Live: Dow futures in the red after 800-point sell-off; European markets lower Stock Market Highlights: Sensex sheds 645 points, Nifty falls 1% as weak global cues drag indices Q4 Results Live Updates: Deepak Fertilisers profit rises 21%; ITC shares slips 2% ahead of earnings Stock Market Crash: From bond yields to expiry, factors that led to a 650-point fall on the Sensex
News Image

Emcure Pharma Q4 Results: Stock rises 8% after net profit grows 64% from last year

Published on: May 22, 2025, 3:10 pm

Source: CNBCTV18

Shares of Emcure Pharmaceuticals Ltd. gained as much as 8% on Thursday, May 22, after the company's fourth quarter results.





The company's net profit for the quarter surged 64% year-on-year to ₹189 crore, compared to a profit of ₹115 crore during the same quarter last year.





Revenue for the period also rose on a year-on-year basis to ₹2,116 crore from ₹1,771 crore, implying a 20% growth.





The board recommended a final dividend of ₹3 per equity share of face value of ₹10 each (at the rate of 30%) for the financial year ended March 31, 2025.





This will be subject to approval of the members of the company at the ensuing Annual General Meeting of the company. The dividend, once approved, will be paid within the prescribed timeline under the Companies Act, 2013.





Shares of Emcure Pharmaceuticals Ltd are trading 8.14% higher after the results announcement at ₹1,161. Despite today's gain, the stock is down 21% so far in 2025.

© Copyright 2025 Stock Gram. All Rights Reserved.

     Privacy Policy